NCT00000208
Completed
Phase 2
Methadone/Buprenorphine Cross-Over Study
ConditionsOpioid-Related Disorders
DrugsBuprenorphine
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Opioid-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Locations
- 1
- Primary Endpoint
- Drug use
- Status
- Completed
- Last Updated
- 20 years ago
Overview
Brief Summary
The purpose of this study is to explore ways to cross patients over from methadone to buprenorphine.
Investigators
Eligibility Criteria
Inclusion Criteria
- •M/F ages 21-
- •Opiate dependence according to DSM-IV critera. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.
Exclusion Criteria
- •Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
Outcomes
Primary Outcomes
Drug use
Opiate craving
Withdrawal symptoms
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on MethadoneOpioid-Related DisordersNCT00000243National Institute on Drug Abuse (NIDA)16
Completed
Phase 3
Buprenorphine Maintenance Protocol - 1Opioid-Related DisordersNCT00000205University of California, Los Angeles
Completed
Phase 4
Buprenorphine and Methadone for Opioid Dependent Chronic Pain PatientsOpiate AddictionNCT00879996State University of New York at Buffalo54
Recruiting
Phase 4
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.Opioid Use DisorderNCT06323824Yale University600
Unknown
Phase 4
Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine PatchesHeroin AddictionNCT00750217Psychiatric University Hospital, Zurich10